News
Chiral Quest Subsidiary Signs License Agreement with
News
Chiral Quest Subsidiary Signs License Agreement with
Read time:
Want a FREE PDF version of This News Story?
Complete the form below and we will email you a PDF version of "Chiral Quest Subsidiary Signs License Agreement with"
First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?
VioQuest's subsidiary Chiral Quest, Inc., (VQPH) signed a licensing agreement granting Merck & Co., Inc. use of its catalysts for the process development and manufacture of single-enantiomer intermediates and active pharmaceutical ingredients.
This agreement provides Merck with access to a broad range of proprietary ligands and catalysts.
Advertisement
